In collaboration with WHO and the Ministry of Health launched ‘Homapak’ a sulfadoxine pyrimethamine + chloroquine combination therapy formulated in age-specific single-use dosage packs for children between the age of 2 months and 5 years. This has been the flagship brand in the Home Based Management of Fever strategy launched in the same year which resulted in an increase in children receiving treatment within 24 hours from 7.3% in 2001 to 55% nationally by the year 2005.

Commenced contract manufacturing of anti-malarials and injectables

Commissioned a Formulation Development Laboratory equipped with stability chambers for accelerated and real time stability studies (First in Uganda)

First to Locally manufacture and launch an Artemesinin Combination Treatment called Duact (Artesunate + Amodiaquine) in Uganda.

Commenced contract packaging of Medical diagnostic devices and reagents.

Launched the first Diabetic drug manufactured in Uganda: Formin (Metformin Hcl) for treatment of Type II Diabetes Mellitus.

Launched the first Anti-hypertensive manufactured in Uganda: Cardipac (Amlodipine)

Launched our official Code of Ethics, “Producing medicines with integrity”.

Winner of the international Frost & Sullivan product leadership of the year award, healthcare industry, Uganda.

Opened a state of the art secondary packaging facility for third party contract packaging of medical products. Currently we carry out secondary packaging of: reproductive health items i.e. Condoms, Oral and Parenteral Contraceptives.

Registered 4 new products Amoxikid, Kamadol Kids, Kamadol Junior and Cardipac 10

Registered Vitacee

Umbigel an antiseptic for umblical cords

Registered Kamadol plus